Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites

Clinical Cancer Research

Volumn 8, Issue 4, 2002, Pages 1108-1114

  Milliken, David ^a   Scotton, Chris ^a   Raju, Shanti ^b   Balkwill, Fran ^a   Wilson, Julia ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; MESSENGER RNA; RIBONUCLEASE;

ARTICLE; ASCITES; ASCITES FLUID; CELL COMPOSITION; CELL COUNT; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HOST CELL; HUMAN; HUMAN CELL; MACROPHAGE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ASCITES; CHEMOKINES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS;

EID: 0036554735     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hirabayashi, K., and Graham, J. Genesis of ascites in ovarian cancer. Am. J. Obstet. Gynecol., 106: 492-497, 1970.
2. Nagy, J. A., Herzberg, K. T., Dvorak, J. M., and Dvorak, H. F. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. Cancer Res., 53: 2631-2643, 1993.
3. Garrison, R. N., Galloway, R. H., and Heuser, L. S. Mechanisms of malignant ascites production. J. Surg. Res., 42: 126-132, 1987.
4. Nagy, J. A., Masse, E. M., Herzberg, K. T., Meyers, M. S., Yeo, K. T., Yeo, T. K., Sioussat, T. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res., 55: 360-368, 1995.
5. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC), 219: 983-985, 1983.
6. Nagy, J. A., Herzberg, K. T., Masse, E. M., Zientara, G. P., and Dvorak, H. F. Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. Cancer Res., 49: 5448-5458, 1989.
7. Feldman, G. B. Lymphatic obstruction in carcinomatous ascites. Cancer Res., 35: 325-332, 1975.
8. Haskill, S., Becker, S., Fowler, W., and Walton, L. Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material. Br. J. Cancer, 45: 728-736, 1982.
9. Sheid, B. Angiogenic effects of macrophages isolated from ascitic fluid aspirated from women with advanced ovarian cancer. Cancer Lett., 62: 153-158, 1992.
10. Veatch, A. L., Carson, L. F., and Ramakrishnan, S. Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int. J. Cancer, 58: 393-399, 1994.
11. Burke, F., Relf, M., Negus, R., and Balkwill, F. A cytokine profile of normal and malignant ovary. Cytokine, 8: 578-585, 1996.
12. Li, B. Y., Mohanraj, D., Olson, M. C., Moradi, M., Twiggs, L., Carson, L. F., and Ramakrishnan, S. Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 α and β genes. Cancer Res., 52: 2248-2252, 1992.
13. Mills, G. B., May, C., Hill, M., Campbell, S., Shaw, P., and Marks, A. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J. Clin. Investig., 86: 851-855, 1990.
14. Punnonen, R., Teisala, K., Kuoppala, T., Bennett, B., and Punnonen, J. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors. Cancer (Phila.), 83: 788-796, 1998.
15. Stromberg, K., Collins, T. J., Gordon, A. W., Jackson, C. L., and Johnson, G. R. Transforming growth factor-α acts as an autocrine growth factor in ovarian carcinoma cell lines. Cancer Res., 52: 341-347, 1992.
16. Negus, R. P., Stamp, G. W., Hadley, J., and Balkwill, F. R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol., 150: 1723-1734, 1997.
17. Hosaka, S., Akahoshi, T., Wada, C., and Kondo, H. Expression of the chemokine superfamily in rheumatoid arthritis. Clin. Exp. Immunol., 97: 451-457, 1994.
18. Mattei, S., Colombo, M. P., Melani, C., Silvani, A., Parmiani, G., and Herlyn, M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer, 56: 853-857, 1994.
19. Van Coillie, E., Froyen, G., Nomiyama, H., Miura, R., Fiten, P., Van Aelst, I., Van Damme, J., and Opdenakker, G. Human monocyte chemotactic protein-2: cDNA cloning and regulated expression of mRNA in mesenchymal cells. Biochem. Biophys. Res. Commun., 231: 726-730, 1997.
20. Altman, D. G. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.
21. Kameyoshi, Y., Dorschner, A., Mallet, A. I., Christophers, E., and Schroder, J. M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med., 176: 587-592, 1992.
22. Scotton, C., Milliken, D., Wilson, J., Raju, S., and Balkwill, F. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br. J. Cancer, 85: 891-897, 2001.
23. Yoong, K. F., Afford, S. C., Jones, R., Aujla, P., Qin, S., Price, K., Hubscher, S. G., and Adams, D. H. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by γ-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology, 30: 100-111, 1999.
24. Baggiolini, M. Chemokines and leukocyte traffic. Nature (Lond.), 392: 565-568, 1998.
25. Robson, R. L., McLoughlin, R. M., Witowski, J., Loetscher, P., Wilkinson, T. S., Jones, S. A., and Topley, N. Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-γ controls neutrophil migration across the mesothelium in vitro and in vivo. J. Immunol., 167: 1028-1038, 2001.
26. Sica, A., Saccani, A., Bottazzi, B., Bernasconi, S., Allavena, P., Gaetano, B., Fei, F., LaRosa, G., Scotton, C., Balkwill, F., and Mantovani, A. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J. Immunol., 164: 733-738, 2000.
27. Kunz, M., Hartmann, A., Flory, E., Toksoy, A., Koczan, D., Thiesen, H. J., Mukaida, N., Neumann, M., Rapp, U. R., Brocker, E. B., and Gillitzer, R. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am. J. Pathol., 155: 753-763, 1999.
28. Negus, R. P., Turner, L., Burke, F., and Balkwilk, F. R. Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J. Leukocyte Biol., 63: 758-765, 1998.
29. Poznansky, M. C., Olszak, I. T., Foxall, R., Evans, R. H., Luster, A. D., and Scadden, D. T. Active movement of T cells away from a chemokine. Nat. Med., 6: 543-548, 2000.
30. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., and Balkwill, F. R. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res., 61: 4961-4965, 2001.
31. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.), 410: 50-56, 2001.
32. Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., Fujii, N., and Imamura, M. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res., 6: 3530-3535, 2000.